Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer
Clinical trial NCT02136836 · UNKNOWN
Trial details
- NCT number
- NCT02136836
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-03-01
- Enrollment
- 860
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.